Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

Mostrar otras versiones (1)

Biological agents have dramatically improved treatment options for patients with severe psoriasis. Etanercept (tumor necrosis factor [TNF] receptor–immunoglobulin fusion protein) is an effective treatment for many psoriasis patients, and blockade of TNF is considered to be its primary action. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaba, Lisa C., Cardinale, Irma, Gilleaudeau, Patricia, Sullivan-Whalen, Mary, Suárez-Fariñas, Mayte, Fuentes-Duculan, Judilyn, Novitskaya, Inna, Khatcherian, Artemis, Bluth, Mark J., Lowes, Michelle A., Krueger, James G.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2007
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150965/
https://www.ncbi.nlm.nih.gov/pubmed/18039949
http://dx.doi.org/10.1084/jem.20071094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150965/
https://www.ncbi.nlm.nih.gov/pubmed/18039949
http://dx.doi.org/10.1084/jem.20071094

Ejemplares similares